Anavex Life Sciences (AVXL) Other financing activities (as filed) (2012 - 2022)
Anavex Life Sciences (AVXL) recorded Other financing activities of $185,361 in fiscal Q3 2022 (quarter ended Jun 30, 2022), down 95.8% from $4.4 million a year earlier and down 50.5% from the prior quarter.
Anavex Life Sciences (AVXL) Other financing activities (as filed) (2012 - 2022) Analysis & Trends
On a TTM basis, Anavex Life Sciences' Other financing activities came in at $5.11 million as of Jun 30, 2022, down 7.3% year-over-year; for FY2019 (ended Sep 30, 2019), it was $50,000, down 50.6% from FY2018.
- Annual Other financing activities has a five-year compound annual growth rate of -42.4% (FY2014 to FY2019).
- Across earlier fiscal years, Other financing activities came in at $101,133 in FY2018.
- Quarterly Other financing activities has ranged from -$24,508 in fiscal Q4 2020 to $4.4 million in fiscal Q3 2021 over the past five years.
- On a year-over-year basis, Other financing activities has declined for three consecutive quarters.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Anavex Life Sciences | 104.75 Mn | -375.33 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -198.00 |
| Jun 30, 2022 | -185,361.00 |
| Mar 31, 2022 | -374,724.00 |
| Dec 31, 2021 | -146,717.00 |
| Dec 31, 2020 | -263,460.00 |
| Jun 30, 2020 | -24,508.00 |
| Dec 31, 2018 | -50,000.00 |
| Sep 30, 2018 | -51,133.00 |
| Jun 30, 2018 | -19,057.00 |
| Mar 31, 2018 | -4.26 Mn |
| Dec 31, 2017 | 4.23 Mn |
| Jun 30, 2017 | 4.42 Mn |
| Mar 31, 2017 | 2.89 Mn |
| Dec 31, 2016 | 15.13 Mn |
| Sep 30, 2016 | 1.36 Mn |
| Mar 31, 2016 | 125,059.00 |
| Dec 31, 2015 | 1.68 Mn |
| Sep 30, 2015 | 8.76 Mn |
| Jun 30, 2015 | 3.08 Mn |
| Dec 31, 2014 | 500,000.00 |
Anavex Life Sciences Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();